GP
About
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 606 investors are based in Tel Aviv, Tel Aviv, Israel.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Tel Aviv, Israel
Contact Information
Find more investors like Galmed
Search Investors